About the Channel

A harm reduction channel run by a practicing pharmacist who applies pharmaceutical knowledge to psychedelic drug interactions, dosing considerations, and safety concerns. The channel covers SSRI and psilocybin interactions, MAOI combinations, lithium and psilocybin (seizure risk), and medication tapering considerations from a clinical pharmacology perspective. Uniquely valuable for the rigorous pharmacological framing.

Editorial Context

For anyone on medications who wants accurate, clinically grounded information about how their prescriptions interact with psilocybin — as opposed to anecdotal reports or forum speculation. The SSRI interaction content specifically is among the most accurate available outside of academic publications.

Key Topics

  • SSRI and psilocybin interactions
  • MAOI combination risks
  • lithium and psilocybin
  • medication tapering
  • pharmacokinetics of psilocybin

Related